Bioceltix Ratios and Metrics

Market cap in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	401	382	431	372	133	172
Market Cap Growth	-35.73%	-11.42%	16.07%	179.48%	-22.49%	-
Enterprise Value	378	359	394	357	130	-
Last Close Price	81.50	77.60	87.60	90.00	38.80	52.20
PB Ratio	14.86	14.15	11.23	35.51	25.82	28.60
P/TBV Ratio	14.86	14.15	11.23	35.51	25.82	28.60
Debt / Equity Ratio	0.02	0.02	0.02	0.02	0.06	0.09
Net Debt / Equity Ratio	-0.87	-0.87	-0.85	-0.87	-0.74	-0.92
Net Debt / EBITDA Ratio	1.62	1.62	2.26	0.67	0.45	1.37
Net Debt / FCF Ratio	1.97	1.97	1.84	0.60	0.47	1.37
Inventory Turnover	-	-	126.03	-	-	-
Quick Ratio	-	-	12.08	5.23	1.94	3.41
Current Ratio	-	-	12.34	5.24	2.68	3.42
Return on Equity (ROE)	-46.44%	-46.44%	-60.95%	-175.28%	-160.02%	-
Return on Assets (ROA)	-	-	-34.54%	-85.92%	-70.62%	-
Return on Capital Employed (ROCE)	-	-	-39.00%	-132.30%	-165.70%	-70.00%
Earnings Yield	-3.78%	-3.98%	-3.45%	-3.68%	-6.71%	-2.56%
FCF Yield	-	-3.13%	-4.13%	-4.09%	-6.19%	-2.35%
Buyback Yield / Dilution	-10.06%	-10.18%	-15.76%	-17.48%	-5.54%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.